These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and tolerability of the new antidepressants. Nelson JC. J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670 [Abstract] [Full Text] [Related]
3. [Applications and safety of modern antidepressants in patients with liver diseases]. Dubarek W, Kucia K. Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965 [Abstract] [Full Text] [Related]
6. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Horst WD, Preskorn SH. J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980 [Abstract] [Full Text] [Related]
7. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Kent JM. Lancet; 2000 Mar 11; 355(9207):911-8. PubMed ID: 10752718 [Abstract] [Full Text] [Related]
13. Clinical utility of venlafaxine in comparison with other antidepressants. Lecrubier Y. Int Clin Psychopharmacol; 1995 Mar 11; 10 Suppl 2():29-35. PubMed ID: 7622815 [Abstract] [Full Text] [Related]